These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 16285894)
1. Dendritic cells as vectors for immunotherapy of tumor and its application for gastric cancer therapy. Wu Y; Wang L; Zhang Y Cell Mol Immunol; 2004 Oct; 1(5):351-6. PubMed ID: 16285894 [TBL] [Abstract][Full Text] [Related]
2. Dendritic cell as therapeutic vaccines against tumors and its role in therapy for hepatocellular carcinoma. Sun K; Wang L; Zhang Y Cell Mol Immunol; 2006 Jun; 3(3):197-203. PubMed ID: 16893500 [TBL] [Abstract][Full Text] [Related]
3. Antigen presentation by dendritic cells and their significance in antineoplastic immunotherapy. Bodey B; Siegel SE; Kaiser HE In Vivo; 2004; 18(1):81-100. PubMed ID: 15011756 [TBL] [Abstract][Full Text] [Related]
4. Dendritic cells and their role in cancer immunotherapy. Jalili A Iran J Immunol; 2007 Sep; 4(3):127-44. PubMed ID: 17767012 [TBL] [Abstract][Full Text] [Related]
5. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity. Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810 [TBL] [Abstract][Full Text] [Related]
6. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
7. Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique. Imura K; Ueda Y; Hayashi T; Itoh T; Shimizu K; Tamai H; Yano Y; Naito K; Kohara J; Nakane K; Matsuura Y; Takeda A; Takeda T; Kawai K; Yamagishi H Int J Oncol; 2006 Sep; 29(3):531-9. PubMed ID: 16865268 [TBL] [Abstract][Full Text] [Related]
8. DC in multiple myeloma immunotherapy. Turtle CJ; Brown RD; Joshua DE; Hart DN Cytotherapy; 2004; 6(2):128-37. PubMed ID: 15203989 [TBL] [Abstract][Full Text] [Related]
9. Dendritic cells as vectors for immunotherapy of cancer. Paczesny S; Ueno H; Fay J; Banchereau J; Palucka AK Semin Cancer Biol; 2003 Dec; 13(6):439-47. PubMed ID: 15001163 [TBL] [Abstract][Full Text] [Related]
10. Dendritic cells from bench to bedside and back. Adema GJ Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337 [TBL] [Abstract][Full Text] [Related]
11. Preparation of fully activated dendritic cells capable of priming tumor-specific cytotoxic T lymphocytes in patients with metastatic cancer using penicillin-killed streptococcus pyogenes (OK432) and anti-CD40 antibody. Kontani K; Teramoto K; Ozaki Y; Sawai S; Tezuka N; Ishida H; Kajino K; Fujino S; Yamauchi A; Taguchi O; Kannagi R; Yokomise H; Ogasawara K Oncol Rep; 2007 Apr; 17(4):895-902. PubMed ID: 17342333 [TBL] [Abstract][Full Text] [Related]
12. Dendritic cell vaccines for cancer immunotherapy. Timmerman JM; Levy R Annu Rev Med; 1999; 50():507-29. PubMed ID: 10073291 [TBL] [Abstract][Full Text] [Related]
13. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells. Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056 [TBL] [Abstract][Full Text] [Related]
14. Fusion of CpG-ODN-stimulating dendritic cells with Lewis lung cancer cells can enhance anti-tumor immune responses. Du YC; Lin P; Zhang J; Lu YR; Ning QZ; Wang Q Tissue Antigens; 2006 May; 67(5):368-76. PubMed ID: 16671943 [TBL] [Abstract][Full Text] [Related]
15. Loading DCs with Ag. Vari F; Hart DN Cytotherapy; 2004; 6(2):111-21. PubMed ID: 15203987 [TBL] [Abstract][Full Text] [Related]
16. Cancer immunotherapy using virally transduced dendritic cells: animal studies and human clinical trials. Mossoba ME; Medin JA Expert Rev Vaccines; 2006 Oct; 5(5):717-32. PubMed ID: 17181444 [TBL] [Abstract][Full Text] [Related]
17. Cancer vaccines for established cancer: how to make them better? Andrews DM; Maraskovsky E; Smyth MJ Immunol Rev; 2008 Apr; 222():242-55. PubMed ID: 18364006 [TBL] [Abstract][Full Text] [Related]
18. The use of dendritic cells in cancer immunotherapy. Nencioni A; Grünebach F; Schmidt SM; Müller MR; Boy D; Patrone F; Ballestrero A; Brossart P Crit Rev Oncol Hematol; 2008 Mar; 65(3):191-9. PubMed ID: 18055210 [TBL] [Abstract][Full Text] [Related]
19. [Dendritic cells--and their possible applications in cancer therapy]. Agger R; Hokland ME Ugeskr Laeger; 2000 Aug; 162(33):4377-81. PubMed ID: 10962960 [TBL] [Abstract][Full Text] [Related]